Reduced BNT162b2 Messenger RNA Vaccine Response in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)-Naive Nursing Home Residents
- PMID: 33993265
- PMCID: PMC8240817
- DOI: 10.1093/cid/ciab447
Reduced BNT162b2 Messenger RNA Vaccine Response in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)-Naive Nursing Home Residents
Abstract
After BNT162b2 messenger RNA vaccination, antibody levels to spike, receptor-binding domain, and virus neutralization were examined in 149 nursing home residents and 110 healthcare worker controls. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-naive nursing home residents' median post-second vaccine dose antibody neutralization titers are one-quarter that of SARS-CoV-2-naive healthcare workers.
Keywords: COVID-19; SARS-CoV-2; geriatrics; vaccine.
© The Author(s) 2021. Published by Oxford University Press for the Infectious Diseases Society of America.
Figures

Update of
-
Reduced BNT162b2 mRNA vaccine response in SARS-CoV-2-naive nursing home residents.medRxiv [Preprint]. 2021 Mar 22:2021.03.19.21253920. doi: 10.1101/2021.03.19.21253920. medRxiv. 2021. Update in: Clin Infect Dis. 2021 Dec 6;73(11):2112-2115. doi: 10.1093/cid/ciab447. PMID: 33791727 Free PMC article. Updated. Preprint.
References
-
- Chidambaram P, Garfield R, Neuman T, Levitt L. Is the end of the long-term care crisis within sight? New COVID-19 cases and deaths in long-term care facilities are dropping. San Francisco, CA: Kaiser Family Foundation, 2021.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous